Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $21 Million - $24.6 Million
-98,766 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $3.18 Million - $3.52 Million
-13,600 Reduced 12.1%
98,766 $24.1 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $24.9 Million - $29.1 Million
112,366 New
112,366 $28 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $24.7 Million - $29.5 Million
-114,366 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $8.45 Million - $9.39 Million
36,000 Added 45.94%
114,366 $29.1 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $4.15 Million - $5.1 Million
-21,000 Reduced 21.13%
78,366 $18.5 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $728,960 - $966,800
-4,000 Reduced 3.87%
99,366 $20.1 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $8.37 Million - $10 Million
48,100 Added 87.03%
103,366 $20 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $833,500 - $977,050
-5,000 Reduced 8.3%
55,266 $10.2 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $3.72 Million - $4.19 Million
-20,571 Reduced 25.45%
60,266 $11.4 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $1.23 Million - $1.44 Million
6,900 Added 9.33%
80,837 $15.7 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $2.44 Million - $2.75 Million
-13,161 Reduced 15.11%
73,937 $15.3 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $507,614 - $570,161
-3,057 Reduced 3.39%
87,098 $16.1 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $14.5 Million - $16.9 Million
-85,545 Reduced 48.69%
90,155 $15.4 Million
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $2.67 Million - $2.98 Million
-15,800 Reduced 8.25%
175,700 $30.6 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $6.16 Million - $7.03 Million
-36,800 Reduced 16.12%
191,500 $35.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
228,300
228,300 $39.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.